Related Experiment Video
Updated: Jul 16, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
[Molecular imaging of psychiatric disorders]
Hidehiko Takahashi1, Tetsuya Suhara
1Department of Molecular Neuroimaging, Clinical Neuroimaging Section, National Institute of Radiological Sciences.
Abstract:
Positron emission tomography (PET) techniques have made it possible to measure changes in target molecular in living human brain. PET can be used to investigate various brain functions such as receptors, transporters, enzymes and various biochemical pathways; therefore, it could be a powerful tool for molecular imaging of psychiatric disorders. Since dopamine is an important molecule for pathophysiology of schizophrenia, we reviewed in vivo imaging studies focusing on dopaminergic transmission in schizophrenia. Dopamine D2 receptor occupancy by antipsychotics and it' s time-course have been measured using PET. This approach can provide in vivo pharmacological evidences of antipsychotics and establish the rational therapeutic strategy. PET is a powerful tool not only in the field of brain research but also drug discovery.
Related Concept Videos
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
